Get the Stockscreener App
10.16
2.78%
-0.29
After Hours:
10.16
Embecta Corp stock is traded at $10.16, with a volume of 830.78K.
It is down -2.78% in the last 24 hours and up +4.85% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$10.45
Open:
$10.25
24h Volume:
830.78K
Relative Volume:
1.33
Market Cap:
$593.78M
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
10.69
EPS:
0.95
Net Cash Flow:
$-30.30M
1W Performance:
-10.72%
1M Performance:
+4.85%
6M Performance:
-43.34%
1Y Performance:
-35.16%
1-Day Range:
$9.96
$10.41
1-Week Range:
$9.96
$11.79
52-Week Range:
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
10.16 | 610.72M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
How does Embecta Corp. compare to its industry peersFinancial News Tracker With High Returns - jammulinksnews.com
Why Embecta Corp. stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it
Will Embecta Corp. Reverse From Oversold ConditionsReal Time Alerts Based on AI Prediction Triggered - metal.it
Fibonacci Levels Suggest Recovery for Embecta Corp.Scalable Portfolio Growth Suggestions Released - metal.it
Embecta Corp.’s Beta Climbs After Market VolatilityWeekly Hot Picks With Buy Confidence Released - metal.it
How does EMBC's Q2 2025 EPS forecast compare to past surprises? - AInvest
How did Embecta's revenue and expenses trend in Q1 2025? - AInvest
Published on: 2025-07-28 16:33:37 - metal.it
Is Embecta Corp. a growth stock or a value stockInvest confidently with professional guidance - jammulinksnews.com
Why is Embecta Corp. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert help - jammulinksnews.com
What are the latest earnings results for Embecta Corp.High-octane investment gains - jammulinksnews.com
Should I hold or sell Embecta Corp. stock in 2025Get timely advice on market trends - jammulinksnews.com
What analysts say about Embecta Corp. stockSuperior return velocity - PrintWeekIndia
Should I buy Embecta Corp. stock before earningsRecord-setting profit potential - jammulinksnews.com
Is Embecta Corp. a good long term investmentDynamic portfolio growth - PrintWeekIndia
What drives Embecta Corp. stock priceAccelerated financial growth - Autocar Professional
Embecta Corp to Host Conference Call Discussing Q3 2025 Financial Results and Operational Updates - Nasdaq
embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewswire
Embecta Earnings Call: Medical Supply Leader to Present Q3 Results and Strategic Updates - Stock Titan
Diabetes Care Market is evolving rapidly Through 2025 To 2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com
Embecta Corp. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
(EMBC) Technical Data - news.stocktradersdaily.com
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):